These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 34567824)
1. Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma. Setayesh T; Colquhoun SD; Wan YY Liver Res; 2020 Dec; 4(4):173-179. PubMed ID: 34567824 [TBL] [Abstract][Full Text] [Related]
2. Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma. Bacigalupo ML; Manzi M; Rabinovich GA; Troncoso MF World J Gastroenterol; 2013 Dec; 19(47):8831-49. PubMed ID: 24379606 [TBL] [Abstract][Full Text] [Related]
3. Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma. Kong F; Jin M; Cao D; Jia Z; Liu Y; Jiang J PeerJ; 2020; 8():e9949. PubMed ID: 32995093 [TBL] [Abstract][Full Text] [Related]
4. Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells. Leung Z; Ko FCF; Tey SK; Kwong EML; Mao X; Liu BHM; Ma APY; Fung YME; Che CM; Wong DKH; Lai CL; Ng IO; Yam JWP J Exp Clin Cancer Res; 2019 Oct; 38(1):423. PubMed ID: 31640796 [TBL] [Abstract][Full Text] [Related]
5. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer. Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001 [TBL] [Abstract][Full Text] [Related]
6. Unraveling the pathophysiologic role of galectin-3 in chronically injured liver. Ezhilarasan D J Cell Physiol; 2023 Apr; 238(4):673-686. PubMed ID: 36745560 [TBL] [Abstract][Full Text] [Related]
7. Exploring the Molecular Interactions of Symmetrical and Unsymmetrical Selenoglycosides with Human Galectin-1 and Galectin-3. Pirone L; Nieto-Fabregat F; Di Gaetano S; Capasso D; Russo R; Traboni S; Molinaro A; Iadonisi A; Saviano M; Marchetti R; Silipo A; Pedone E Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955408 [TBL] [Abstract][Full Text] [Related]
8. Galectins in epithelial-mesenchymal transition: roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis. Perez-Moreno E; Oyanadel C; de la Peña A; Hernández R; Pérez-Molina F; Metz C; González A; Soza A Biol Res; 2024 Apr; 57(1):14. PubMed ID: 38570874 [TBL] [Abstract][Full Text] [Related]
9. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis. Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794 [TBL] [Abstract][Full Text] [Related]
10. Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma. Jiang SS; Weng DS; Wang QJ; Pan K; Zhang YJ; Li YQ; Li JJ; Zhao JJ; He J; Lv L; Pan QZ; Xia JC J Transl Med; 2014 Sep; 12():273. PubMed ID: 25260879 [TBL] [Abstract][Full Text] [Related]
11. Galectin-1 Promotes Metastasis in Gastric Cancer Through a Sphingosine-1-Phosphate Receptor 1-Dependent Mechanism. You X; Wang Y; Wu J; Liu Q; Chen D; Tang D; Wang D Cell Physiol Biochem; 2018; 51(1):11-30. PubMed ID: 30453284 [TBL] [Abstract][Full Text] [Related]
12. The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model. Setayesh T; Hu Y; Vaziri F; Wei D; Wan YY Biomark Res; 2024 Oct; 12(1):122. PubMed ID: 39402682 [TBL] [Abstract][Full Text] [Related]
13. Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling. Zhang PF; Li KS; Shen YH; Gao PT; Dong ZR; Cai JB; Zhang C; Huang XY; Tian MX; Hu ZQ; Gao DM; Fan J; Ke AW; Shi GM Cell Death Dis; 2016 Apr; 7(4):e2201. PubMed ID: 27100895 [TBL] [Abstract][Full Text] [Related]
14. The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children. de Oliveira FL; Panera N; De Stefanis C; Mosca A; D'Oria V; Crudele A; De Vito R; Nobili V; Alisi A Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337151 [TBL] [Abstract][Full Text] [Related]
15. The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition. Cao Z; Sun B; Zhao X; Zhang Y; Gu Q; Liang X; Dong X; Zhao N Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264434 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells. Zheng D; Hu Z; He F; Gao C; Xu L; Zou H; Wu Z; Jiang X; Wang J Oncol Rep; 2014 Jul; 32(1):411-8. PubMed ID: 24807674 [TBL] [Abstract][Full Text] [Related]
17. Galectin-1 induces metastasis and epithelial-mesenchymal transition (EMT) in human ovarian cancer cells via activation of the MAPK JNK/p38 signalling pathway. Zhu J; Zheng Y; Zhang H; Liu Y; Sun H; Zhang P Am J Transl Res; 2019; 11(6):3862-3878. PubMed ID: 31312395 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
19. Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives. Li CH; Chang YC; Chan MH; Yang YF; Liang SM; Hsiao M Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572346 [TBL] [Abstract][Full Text] [Related]
20. Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway. Chong Y; Tang D; Gao J; Jiang X; Xu C; Xiong Q; Huang Y; Wang J; Zhou H; Shi Y; Wang D Oncotarget; 2016 Dec; 7(50):83611-83626. PubMed ID: 27835885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]